SCHEMBL25451998

SCHEMBL25451998

CCc1ccc(-c2cc(-c3ccccc3)cc[n+]2C)c(C)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.36
NPC1 O15118 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
ALDH1A1 P00352 2/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
MAPK1 P28482 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
SLC22A2 O15244 1/20 0.36
SLC22A1 O15245 1/20 0.36
SLC22A3 O75751 1/20 0.36
SLC6A4 P31645 1/20 0.36
KDM4E B2RXH2 2/20 0.36
HTT P42858 1/20 0.36
BCL2 P10415 1/20 0.35
TP53 P04637 1/20 0.35
ESR2 Q92731 1/20 0.34
MAPKAPK2 P49137 1/20 0.33
RCE1 Q9Y256 1/20 0.33
CYP1A2 P05177 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25452167 0.89 BCL2 (0.38) RAB9ANPC1SMN1; SMN2ALDH1A1LMNA
SCHEMBL25970419 0.86 EDNRB (0.36) RAB9ANPC1SMN1; SMN2ALDH1A1LMNA
SCHEMBL25452023 0.85 PPARG (0.33) RAB9ANPC1SMN1; SMN2ALDH1A1SLC22A2
SCHEMBL25543959 0.85 SLC22A2 (0.42) RAB9ANPC1SMN1; SMN2ALDH1A1LMNA
SCHEMBL25451996 0.82 RAB9A (0.40) RAB9ANPC1SMN1; SMN2ALDH1A1LMNA
SCHEMBL25446019 0.81 RAB9A (0.41) RAB9ANPC1SMN1; SMN2ALDH1A1LMNA
SCHEMBL25450576 0.81 NPC1 (0.34) RAB9ANPC1SMN1; SMN2ALDH1A1LMNA
SCHEMBL25452025 0.81 NPC1 (0.40) RAB9ANPC1SMN1; SMN2ALDH1A1LMNA
SCHEMBL25449556 0.81 SLC22A2 (0.44) RAB9ANPC1SMN1; SMN2ALDH1A1SLC22A2
SCHEMBL25976600 0.78 SLC22A2 (0.41) RAB9ANPC1SMN1; SMN2ALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230240130-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-07-27 US disclosed
US-11653558-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-05-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230240130-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OSBPL3, LBR, RBM3 RAB9A 628/4885NPC1 1729/4885SMN1; SMN2 3122/4885
US-11653558-B2 Organic electroluminescent materials and devices OSBPL3, LBR, LOXL3 RAB9A 873/4885NPC1 1255/4885SMN1; SMN2 2748/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.